Administration guidelines for Cuvitru 200 mg/ml solution via the syringe driver technique.

Cuvitru (immune globulin subcutaneous, human) is administered via the subcutaneous route. The administration via the syringe driver technique refers to using a pump to slowly infuse the medication into the subcutaneous tissue. 


Here is a step-by-step guide:

  1. Preparation:
    • Hand Hygiene: Wash your hands thoroughly as per hospital policy.
    • Gather Supplies: Cuvitru vials, syringes, subcutaneous needles, alcohol wipes, sterile gauze, sharps container, and a clean work area.
  2. Inspect the Vial:
    • Ensure the solution in the vial is clear and free from particles.
    • Check the expiration date on the vials.
  3. Pre-fill the Syringe:
    • Use an alcohol wipe to sanitize the vial top.
    • Withdraw the prescribed dose into the syringe, removing any air bubbles.
    • Prime the subcutaneous needle set with the Cuvitru
  4. Select the Infusion Site:
    • Choose an area with enough subcutaneous tissue such as the abdomen, thighs.
    • Clean the site with an alcohol wipe and let it dry completely.
    • Insert the needle at a 45 to 90-degree angle.
    • More than one site and pump can be used simultaneously.
  5. Start the infusion
    • Attach the syringe to the syringe driver according to the manufacturer’s instruction.
    • Turn on the syringe driver to begin the infusion at the set rate: 10ml/hr for the first 10 minutes increasingly gradually to a maximum rate of 20ml/hr for the remainder of the infusion.
    • Once the infusion is complete, turn off the syringe driver.
    • Gently remove the needle and apply pressure to the site with sterile gauze.
    • Dispose of the used needle and syringe as per local policy.
  6. Post-Administration:
    • Monitor the patient for 1 hour post infusion for any side effects at the infusion site, such as redness or swelling.

 

For more detailed infusion information and side effects please visit https://www.medicines.ie/medicines/cuvitru-200-mg-ml-solution-for-subcutaneous-inje31755/spc